Meta-analyses revealed a high correlation between IL-17 overexpression and advanced-stage NSCLC (III/IV), overall survival (OS), as well as disease-free survival (DFS), suggesting that IL-17 promotes the growth and progression of NSCLC.70 This evidence concerns the gene IL17A and non-small cell lung carcinoma.